
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A next-gen pharmatech company is seeking a Drug Discovery Program Leader in London. This role involves managing drug discovery projects, leading interdisciplinary teams, and leveraging innovative technology. The ideal candidate has a strong project management background, scientific expertise, and is committed to advancing drug development. This position allows for remote work flexibility, with a focus on critical therapeutic areas and strong collaboration with partners.
Join to apply for the Drug Discovery Program leader role at AQEMIA.
Get AI-powered advice on this job and more exclusive features.
AQEMIA is a next‑gen pharmatech company generating one of the world’s fastest‑growing drug discovery pipelines.
Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno‑oncology.
Our unique approach leverages quantum‑inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data.
We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimisation.
Within Aqemia’s drug discovery portfolio team, Program Leaders play a critical role as they drive our drug discovery projects.
The objective of such projects is to invent therapeutic molecules (hits / leads) against a given target protein and related disease, leveraging our unique technology combining new physics and machine‑learning algorithms.
Projects can be in collaboration with pharmaceutical companies or within Aqemia’s internal project portfolio.
A project is run by a core team— a drug hunter, a project leader, plus part of a chemist and biologist—and relies on the technology and ways of working developed by Aqemia’s platform.
Projects typically last several months and a Project Leader can manage up to 2‑3 projects at a time.
At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast‑growing company and team.
Expanding Drug Discovery Pipeline: Focused on critical therapeutic areas like oncology, CNS, immuno‑inflammation… with in vivo proof of concept/patent‑stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.
Interdisciplinary Team: Brilliant talent from tech and life sciences.
DeepTech Recognition: Part of French Tech 120 and France 2030.
Prime Location: Based in central Paris and London (King’s Cross) with the possibility of 2 remote days per week.
International Environment: The work language is English—relocation support and French lessons granted if needed.
Strong Financial Backing: $100M raised from leading European and international investors.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analysing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgement. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.